Human recombinant ACE2 reduces the progression of diabetic nephropathy (vol 59, pg 529, 2010)

被引：0
|
作者：
Oudit, G. Y.
Liu, G. C.
Zhong, J.
Basu, R.
Chow, F. L.
Zhou, J.
Loibner, H.
Janzek, E.
Schuster, M.
Penninger, J. M.
Herzenberg, A. M.
Kassiri, Z.
Scholey, J. W.
机构：
来源：
DIABETES | 2010年 / 59卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1113 / 1114
页数：2
相关论文
共 50 条
  • [31] Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts
    Marfella, Raffaele
    D'Onofrio, Nunzia
    Mansueto, Gelsomina
    Grimaldi, Vincenzo
    Trotta, Maria Consiglia
    Sardu, Celestino
    Sasso, Ferdinando Carlo
    Scisciola, Lucia
    Amarelli, Cristiano
    Esposito, Salvatore
    D'Amico, Michele
    Golino, Paolo
    De Feo, Marisa
    Signoriello, Giuseppe
    Paolisso, Pasquale
    Gallinoro, Emanuele
    Vanderheyden, Marc
    Maiello, Ciro
    Balestrieri, Maria Luisa
    Barbato, Emanuele
    Napoli, Claudio
    Paolisso, Giuseppe
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [32] Antagonism of angiotensin 1–7 prevents the therapeutic effects of recombinant human ACE2
    Vaibhav B. Patel
    Abhijit Takawale
    Tharmarajan Ramprasath
    Subhash K. Das
    Ratnadeep Basu
    Maria B. Grant
    David A. Hall
    Zamaneh Kassiri
    Gavin Y Oudit
    Journal of Molecular Medicine, 2015, 93 : 1003 - 1013
  • [33] Genetic Landscape of the ACE2 Coronavirus Receptor (vol 145, pg 1398, 2021)
    Yang
    CIRCULATION, 2022, 146 (01) : E4 - E4
  • [34] ACE2 inhibition worsens glomerular injury associated with increased ACE expression in streptozotocin-induced diabetic mice (vol 72, pg 614, 2007)
    不详
    KIDNEY INTERNATIONAL, 2007, 72 (08) : 1034 - 1034
  • [35] Response to 'Angiotensin-converting enzyme 2 (ACE2) gene and protein expression in diabetic patients without nephropathy'
    Reich, Heather N.
    Oudit, Gavin Y.
    Penninger, Josef M.
    Scholey, James W.
    Herzenberg, Andrew M.
    KIDNEY INTERNATIONAL, 2009, 75 (10) : 1119 - 1119
  • [36] Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication
    Xiaocong Pang
    Yimin Cui
    Yizhun Zhu
    Acta Pharmacologica Sinica, 2020, 41 : 1255 - 1257
  • [37] ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes (vol 57, pg 1018, 2008)
    Tikellis, C.
    Bialkowski, K.
    Pete, J.
    Sheehy, K.
    Su, Q.
    Johnston, C.
    Cooper, M. E.
    Thomas, M. C.
    DIABETES, 2011, 60 (01) : 360 - 360
  • [38] Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication
    Pang, Xiaocong
    Cui, Yimin
    Zhu, Yizhun
    ACTA PHARMACOLOGICA SINICA, 2020, 41 (09) : 1255 - 1257
  • [39] RECOMBINANT HUMAN ACE2 ATTENUATES PRESSURE OVERLOAD-INDUCED PATHOLOGICAL MYOCARDIAL REMODELING
    Zhong, J.
    Oudit, G. Y.
    Basu, R.
    Chow, F. L.
    Shuster, M.
    Loibner, H.
    Wang, X.
    Penninger, J. M.
    Kassiri, Z.
    CANADIAN JOURNAL OF CARDIOLOGY, 2010, 26 : 71D - 72D
  • [40] Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2
    Patel, Vaibhav B.
    Takawale, Abhijit
    Ramprasath, Tharmarajan
    Das, Subhash K.
    Basu, Ratnadeep
    Grant, Maria B.
    Hall, David A.
    Kassiri, Zamaneh
    Oudit, Gavin Y.
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2015, 93 (09): : 1003 - 1013
12345